The DOI matches its Crossref record; 69 of the 69 references it cites were found in a registry or an index.
The Polyol Pathway as a Mechanism for Diabetic Retinopathy: Attractive, Elusive, and Resilient
Open accessAbstract
The polyol pathway is a two‐step metabolic pathway in which glucose is reduced to sorbitol, which is then converted to fructose. It is one of the most attractive candidate mechanisms to explain, at least in part, the cellular toxicity of diabetic hyperglycemia because (i) it becomes active when intracellular glucose concentrations are elevated, (ii) the two enzymes are present in human tissues and organs that are sites of diabetic complications, and (iii) the products of the pathway and the altered balance of cofactors generate the types of cellular stress that occur at the sites of diabetic complications. Inhibition (or ablation) of aldose reductase, the first and rate‐limiting enzyme in the pathway, reproducibly prevents diabetic retinopathy in diabetic rodent models, but the results of a major clinical trial have been disappointing. Since then, it has become evident that truly informative indicators of polyol pathway activity and/or inhibition are elusive, but are likely to be other than sorbitol levels if meant to predict accurately tissue consequences. The spectrum of abnormalities known to occur in human diabetic retinopathy has enlarged to include glial and neuronal abnormalities, which in experimental animals are mediated by the polyol pathway. The endothelial cells of human retinal vessels have been noted to have aldose reductase. Specific polymorphisms in the promoter region of the aldose reductase gene have been found associated with susceptibility or progression of diabetic retinopathy. This new knowledge has rekindled interest in a possible role of the polyol pathway in diabetic retinopathy and in methodological investigation that may prepare new clinical trials. Only new drugs that inhibit aldose reductase with higher efficacy and safety than older drugs will make possible to learn if the resilience of the polyol pathway means that it has a role in human diabetic retinopathy that should not have gone undiscovered.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(1993) · New England Journal of Medicine · doi:10.1056/nejm199309303291401 · Cited by 24,667
Barber, A. J., Lieth, E., Khin, S. A., Antonetti, D. A., Buchanan, A. G., & Gardner, T. W. (1998) · Journal of Clinical Investigation · doi:10.1172/jci2425 · Cited by 1,295
Hyperglycemic Pseudohypoxia and Diabetic Complications
Williamson, J. R., Chang, K., Frangos, M., Hasan, K. S., Ido, Y., Kawamura, T., Nyengaard, J. R., Den Enden, M. V., Kilo, C., & Tilton, R. G. (1993) · Diabetes · doi:10.2337/diab.42.6.801 · Cited by 1,105
Vascular NAD(P)H oxidases: specific features, expression, and regulation
Lassègue, B., & Clempus, R. E. (2003) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00758.2002 · Cited by 1,032
Effect of intensive therapy on the microvascular complications of type 1 diabetes mellitus
The Writing Team for the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group (2002) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.287.19.2563 · Cited by 941
Hammes, H.-P., Du, X., Edelstein, D., Taguchi, T., Matsumura, T., Ju, Q., Lin, J., Bierhaus, A., Nawroth, P., Hannak, D., et al. (2003) · Nature Medicine · doi:10.1038/nm834 · Cited by 785
The Sorbitol Pathway and the Complications of Diabetes
Steinmetz, P. R., Balko, C., & Gabbay, K. H. (1973) · New England Journal of Medicine · doi:10.1056/nejm197304192881609 · Cited by 759
Accelerated death of retinal microvascular cells in human and experimental diabetic retinopathy.
Mizutani, M., Kern, T. S., & Lorenzi, M. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118746 · Cited by 706
Self-citationMetabolic Control and Disease.
(1980) · Annals of Internal Medicine · doi:10.7326/0003-4819-92-6-887_2 · Cited by 541
Aminoguanidine treatment inhibits the development of experimental diabetic retinopathy.
Hammes, H. P., Martin, S., Federlin, K., Geisen, K., & Brownlee, M. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.24.11555 · Cited by 524
Müller cell changes in human diabetic retinopathy.
Mizutani, M., Gerhardinger, C., & Lorenzi, M. (1998) · Diabetes · doi:10.2337/diabetes.47.3.445 · Cited by 481
Self-citationThe Ins2AkitaMouse as a Model of Early Retinal Complications in Diabetes
Barber, A. J., Antonetti, D. A., Kern, T. S., Reiter, C. E. N., Soans, R. S., Krady, J. K., Levison, S. W., Gardner, T. W., & Bronson, S. K. (2005) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.04-1340 · Cited by 472
Lieth, E., Barber, A. J., Xu, B., Dice, C., Ratz, M. J., Tanase, D., & Strother, J. M. (1998) · Diabetes · doi:10.2337/diabetes.47.5.815 · Cited by 467
Death of Retinal Neurons in Streptozotocin-Induced Diabetic Mice
Martin, P. M., Roon, P., Van Ells, T. K., Ganapathy, V., & Smith, S. B. (2004) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.04-0247 · Cited by 453
Implications of the United Kingdom Prospective Diabetes Study
American Diabetes Association (2003) · Diabetes Care · doi:10.2337/diacare.26.2007.s28 · Cited by 449
The AGE Inhibitor Pyridoxamine Inhibits Development of Retinopathy in Experimental Diabetes
Stitt, A., Gardiner, T. A., Anderson, N. L., Canning, P., Frizzell, N., Duffy, N., Boyle, C., Januszewski, A. S., Chachich, M., Baynes, J. W., et al. (2002) · Diabetes · doi:10.2337/diabetes.51.9.2826 · Cited by 355
Pathogenesis of Diabetic Retinopathy
Engerman, R. L. (1989) · Diabetes · doi:10.2337/diab.38.10.1203 · Cited by 353
IGF-I specifically enhances axon outgrowth of corticospinal motor neurons
Özdinler, P. H., & Macklis, J. D. (2006) · Nature Neuroscience · doi:10.1038/nn1789 · Cited by 341 · cited 1×
“The pharmaceutical industry may need to apply to the problem some new thinking, especially in view of the fact that ARIs could become the “one drug-option” for diabetic retinopathy only if usable at doses that inhibit AR and flux through the pathway more substantially than the older drugs.”
BackgroundPolyol pathway and diabetic peripheral neuropathy
Oates, P. J. (2002) · International Review of Neurobiology · doi:10.1016/s0074-7742(02)50082-9 · Cited by 322
Lee, A. Y., Chung, S. K., & Chung, S. S. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.7.2780 · Cited by 310
Vascular Damage in a Mouse Model of Diabetic Retinopathy: Relation to Neuronal and Glial Changes
Feit-Leichman, R. A., Kinouchi, R., Takeda, M., Fan, Z., Mohr, S., Kern, T. S., & Chen, D. F. (2005) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.04-1361 · Cited by 281
Asnaghi, V., Gerhardinger, C., Hoehn, T., Adeboje, A., & Lorenzi, M. (2003) · Diabetes · doi:10.2337/diabetes.52.2.506 · Cited by 279
Self-citationExperimental Galactosemia Produces Diabetic-like Retinopathy
Engerman, R. L., & Kern, T. S. (1984) · Diabetes · doi:10.2337/diab.33.1.97 · Cited by 278
Pharmacological Inhibition of Diabetic Retinopathy
Kern, T. S., & Engerman, R. L. (2001) · Diabetes · doi:10.2337/diabetes.50.7.1636 · Cited by 277
The role of müller cells in the formation of the blood-retinal barrier
Tout, S., Chan-Ling, T., Holländer, H., & Stone, J. (1993) · Neuroscience · doi:10.1016/0306-4522(93)90473-s · Cited by 268
Expression of Acute-Phase Response Proteins in Retinal Müller Cells in Diabetes
Gerhardinger, C., Costa, M. B., Coulombe, M. C., Toth, I., Hoehn, T., & Grosu, P. (2005) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.04-0860 · Cited by 261
Kern, T. S., Tang, J., Mizutani, M., Kowluru, A., Nagaraj, R. H., Romeo, G. R., Podestà, F., & Lorenzi, M. (2000) · PubMed · Cited by 253
Self-citationZheng, L., Szabó, C., & Kern, T. S. (2004) · Diabetes · doi:10.2337/diabetes.53.11.2960 · Cited by 238
STUDIES OF THE RETINAL CAPILLARIES IN RELATION TO DIABETIC AND OTHER RETINOPATHIES
Ashton, N. (1963) · British Journal of Ophthalmology · doi:10.1136/bjo.47.9.521 · Cited by 237
Studies of Rat and Human Retinas Predict a Role for the Polyol Pathway in Human Diabetic Retinopathy
Dagher, Z., Park, Y. S., Asnaghi, V., Hoehn, T., Gerhardinger, C., & Lorenzi, M. (2004) · Diabetes · doi:10.2337/diabetes.53.9.2404 · Cited by 231
Self-citationA Randomized Trial of Sorbinil, an Aldose Reductase Inhibitor, in Diabetic Retinopathy
(1990) · Archives of Ophthalmology · doi:10.1001/archopht.1990.01070110050024 · Cited by 228
Hotta, N., Toyota, T., Matsuoka, K., Shigeta, Y., Kikkawa, R., Kaneko, T., Takahashi, A., Sugimura, K., Koike, Y., Ishii, J., et al. (2001) · Diabetes Care · doi:10.2337/diacare.24.10.1776 · Cited by 217
Identification of Fructose 3-Phosphate in the Lens of Diabetic Rats
Szwergold, B. S., Kappler, F., & Brown, T. R. (1990) · Science · doi:10.1126/science.2300805 · Cited by 213
Cheung, A. K. H., Fung, M. K. L., Lo, A. C. Y., Lam, T. T. L., So, K. F., Chung, S. S. M., & Chung, S. K. (2005) · Diabetes · doi:10.2337/diabetes.54.11.3119 · Cited by 207
Early cellular and molecular changes induced by diabetes in the retina
Lorenzi, M., & Gerhardinger, C. (2001) · Diabetologia · doi:10.1007/s001250100544 · Cited by 205
Self-citationObrosova, I. G., Minchenko, A. G., Vasupuram, R., White, L., Abatan, O. I., Kumagai, A. K., Frank, R. N., & Stevens, M. J. (2003) · Diabetes · doi:10.2337/diabetes.52.3.864 · Cited by 201
Obrosova, I. G., Pacher, P., Szabó, C., Zsengeller, Z., Hirooka, H., Stevens, M. J., & Yorek, M. A. (2005) · Diabetes · doi:10.2337/diabetes.54.1.234 · Cited by 178
Human aldose reductase expression accelerates diabetic atherosclerosis in transgenic mice
Vikramadithyan, R. K. (2005) · Journal of Clinical Investigation · doi:10.1172/jci24819 · Cited by 176
GLUT1 glucose transporter expression in the diabetic and nondiabetic human eye.
Kumagai, A. K., Glasgow, B. J., & Pardridge, W. M. (1994) · PubMed · Cited by 170
Kador, P. F. (1990) · Archives of Ophthalmology · doi:10.1001/archopht.1990.01070110117035 · Cited by 154
Zhang, J., Gerhardinger, C., & Lorenzi, M. (2002) · Diabetes · doi:10.2337/diabetes.51.12.3499 · Cited by 149
Self-citationImmunohistochemical Localization of Aldose Reductase: II. Rat Eye and Kidney
Ludvigson, M. A., & Sorenson, R. L. (1980) · Diabetes · doi:10.2337/diab.29.6.450 · Cited by 146
Glia Cells of the Monkey Retina—II. Müller Cells
Distler, C., & Dreher, Z. (1996) · Vision Research · doi:10.1016/0042-6989(96)00005-3 · Cited by 145
Aldose Reductase in Diabetic Microvascular Complications
Chung, S. S. M., & Chung, S. S. M. (2005) · Current Drug Targets · doi:10.2174/1389450054021891 · Cited by 143
Sun, W., Oates, P. J., Coutcher, J. B., Gerhardinger, C., & Lorenzi, M. (2006) · Diabetes · doi:10.2337/db06-0138 · Cited by 129
Self-citationBril, V., Buchanan, R. A., & the Ranirestat Study Group* (2006) · Diabetes Care · doi:10.2337/diacare.29.01.06.dc05-1447 · Cited by 128
Neuronal versus glial cell swelling in the ischaemic retina
Bringmann, A., Uckermann, O., Pannicke, T., Iandiev, I., Reichenbach, A., & Wiedemann, P. (2005) · Acta Ophthalmologica Scandinavica · doi:10.1111/j.1600-0420.2005.00565.x · Cited by 122
The Effect of Oxidation on Sorbitol Pathway Kinetics
Barnett, P. A., González, R. G., Chylack, L. T., & Cheng, H. (1986) · Diabetes · doi:10.2337/diab.35.4.426 · Cited by 121
Mechanism of Human Aldehyde Reductase: Characterization of the Active Site Pocket
Barski, O. A., Gabbay, K. H., Grimshaw, C. E., & Bohren, K. M. (1995) · Biochemistry · doi:10.1021/bi00035a036 · Cited by 120
Localization of Aldose Reductase in the Human Eye
Akagi, Y., Yajima, Y., Kador, P. F., Kuwabara, T., & Kinoshita, J. H. (1984) · Diabetes · doi:10.2337/diab.33.6.562 · Cited by 117
Aldose Reductase-Deficient Mice Develop Nephrogenic Diabetes Insipidus
Ho, H. T. B., Chung, S. K., Law, J. W. S., Ko, B. C. B., Tam, S., Brooks, H. L., Knepper, M. A., & Chung, S. S. M. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.16.5840-5846.2000 · Cited by 105
Implications of the United Kingdom Prospective Diabetes Study
American Diabetes Association (1998) · Diabetes Care · doi:10.2337/diacare.21.12.2180 · Cited by 98
Motoko, T., Fujii, J., Teshima, T., Keiichiro, S., Shiba, T., & Taniguchi, N. (1993) · Gene · doi:10.1016/0378-1119(93)90728-l · Cited by 92
Early diabetes-induced biochemical changes in the retina: comparison of rat and mouse models
Obrosova, I. G., Drel, V. R., Kumagai, A. K., Szábo, C., Pacher, P., & Stevens, M. J. (2006) · Diabetologia · doi:10.1007/s00125-006-0356-7 · Cited by 92
Demaine, A. G. (2003) · Current Medicinal Chemistry · doi:10.2174/0929867033457359 · Cited by 89
Bril, V., Buchanan, R. A., & the AS-3201 Study Group (2004) · Diabetes Care · doi:10.2337/diacare.27.10.2369 · Cited by 87
Shah, V. O., Scavini, M., Nikolic, J., et al. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.8.5028 · Cited by 79
Mohn, A., Matyka, K. A., Harris, D. A., Ross, K. M., Edge, J., & Dunger, D. B. (1999) · Diabetes Care · doi:10.2337/diacare.22.1.27 · Cited by 75
Sun, W., Gerhardinger, C., Dagher, Z., Hoehn, T., & Lorenzi, M. (2005) · Diabetes · doi:10.2337/diabetes.54.12.3418 · Cited by 63
Self-citationDevelopmental and Physiological Regulation of Aldose Reductase mRNA Expression in Renal Medulla
Bondy, C. A., Lightman, S. L., & Lightman, S. L. (1989) · Molecular Endocrinology · doi:10.1210/mend-3-9-1409 · Cited by 57
Aldose Reductase Expression in Human Diabetic Retina and Retinal Pigment Epithelium
Vinores, S. A., Campochiaro, P. A., Williams, E. H., May, E. E., Green, W. R., & Sorenson, R. L. (1988) · Diabetes · doi:10.2337/diab.37.12.1658 · Cited by 56
Kato, N., Yashima, S., Suzuki, T., Nakayama, Y., & Jomori, T. (2003) · Journal of Diabetes and its Complications · doi:10.1016/s1056-8727(02)00193-9 · Cited by 56
Neuenschwander, H., Takahashi, Y., & Kador, P. F. (1997) · Journal of Ocular Pharmacology and Therapeutics · doi:10.1089/jop.1997.13.517 · Cited by 44
Shah, V. O. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.83.8.2886 · Cited by 38
Cameron, N. E., & Cotter, M. A. (1992) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1992.tb13389.x · Cited by 35
Surgical and Other Treatments of Diabetic Macular Edema: An Update
Christoforidis, J. B., & Amico, D. J. D. (2004) · International Ophthalmology Clinics · doi:10.1097/00004397-200404410-00015 · Cited by 31
The role of Muller cells in the formation of the blood-retinal barrier. Neuroscience
Tout, S., Ling, T. C., Holländer, H., & Stone, J. (1993) · Cited by 25
Mechanisms and strategies for prevention in diabetic retinopathy
Lorenzi, M. (2006) · Current Diabetes Reports · doi:10.1007/s11892-006-0019-6 · Cited by 6
Self-citation(2002) · Diabetes Care · doi:10.2337/diacare.25.2.413 · Cited by 2
Cited by
Kang, Q., & Yang, C. (2020) · Redox Biology · doi:10.1016/j.redox.2020.101799 · Cited by 1,066
Giri, B., Dey, S., Das, T., Sarkar, M., Banerjee, J., & Dash, S. K. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.07.157 · Cited by 635
Endothelial Cell Metabolism in Normal and Diseased Vasculature
Eelen, G., de Zeeuw, P., Simons, M., & Carmeliet, P. (2015) · Circulation Research · doi:10.1161/circresaha.116.302855 · Cited by 627
Eelen, G., de Zeeuw, P., Treps, L., Harjes, U., Wong, B. W., & Carmeliet, P. (2018) · Physiological Reviews · doi:10.1152/physrev.00001.2017 · Cited by 572
Fructose metabolism and metabolic disease
Hannou, S. A., Haslam, D. E., McKeown, N. M., & Herman, M. A. (2018) · Journal of Clinical Investigation · doi:10.1172/jci96702 · Cited by 561
Metadata
- Authors
- Lorenzi, M.
- Venue
- Journal of Diabetes Research
- Publisher
- Wiley
- Published
- 2007-01
- Volume
- 2007
- Issue
- 1
- Pages
- 61038-61038
- ISSN
- 2314-6745 (ISSN-L)
- 2314-6753
- OpenAlex
- W2157757005
- Cited by
- 472
- References
- 69
- FWCI
- 4.21
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.